Emiliem
Berkeley
About Emiliem
Emiliem, Inc is a private biotechnology company focused on understanding the molecular determinants of target modulation as it relates to the efficacy of therapeutics and to potential adverse drug reactions. The company is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Mar 2008)
- Website: emiliem.com
- Phone: (415) 421-0222
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/emiliem-3070185 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.